Silevimig
斯乐韦米
Report date: 2026/04/08 16:01:30
Base Information
Drug NameSilevimig
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesChongqing Genrix Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A